Physician Associates Credit

Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14.25 AAPA Category 1 CME Credits. Physician Associates should only claim credit commensurate with the extent of their participation.

Physician Credit

Medical Education Resources designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Objectives

After completing this activity, the participant should be better able to:

1. Identify effective management strategies for psoriasis, including treatment-resistant cases and emerging insights such as immune drift that influence long-term therapy selection.

2. Select appropriate medical and surgical treatments for vitiligo, including correct regimens and available surgical options.

3. Evaluate and manage hidradenitis suppurativa using outpatient deroofing procedures, including patient selection and technique application.

4. Discuss treatment considerations and management pearls for infantile hemangiomas, including ulcerated presentations.

5. Apply knowledge of vulvar microanatomy to distinguish between vulvar dermatoses.

Disclosure of Relevant Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.